The process for FDA certification (also referred to as FDA approval or registration) in the United States depends on the type of product and its classification. For medical devices, including in vitro diagnostic (IVD) devices, the process generally involves the following steps:

1. Determine the Classification of the Device

• Class I: Low-risk devices, usually subject to general controls (e.g., gloves, dental floss).
• Class II: Moderate-risk devices, generally requiring premarket notification (510(k)) unless exempt (e.g., infusion pumps, X-ray machines).
• Class III: High-risk devices, typically requiring premarket approval (PMA) (e.g., pacemakers, heart valves).

2. Establishment Registration and Device Listing

• Establishment Registration: Manufacturers must register their establishments with the FDA, even if they are based outside the U.S.
• Device Listing: Manufacturers must list the devices they intend to market with the FDA.

3. Prepare and Submit the Required Documentation

Depending on the device classification:

• Class I devices: Many Class I devices are exempt from premarket notification, but they still require establishment registration.
• Class II devices (510(k)): Most Class II devices require a 510(k) premarket notification. This submission demonstrates that the device is substantially equivalent to a legally marketed device.
  • Prepare 510(k) submission: This includes device description, labeling, intended use, and performance data, if applicable.
  • Submit to FDA: The FDA reviews the submission and, if it finds the device to be substantially equivalent, issues clearance for the device to be marketed.
• Class III devices (PMA): Devices requiring PMA must undergo a more rigorous premarket approval process.
  • Prepare PMA application: This includes clinical trial data, device testing data, manufacturing information, and labeling.
  • Submit to FDA: The FDA conducts a thorough review, often involving advisory committees and clinical trials, before granting approval.

4. FDA Review Process

• 510(k) Review: FDA reviews whether the device is substantially equivalent to a predicate device.
• PMA Review: The FDA reviews safety, efficacy, and manufacturing data, and may require advisory panel input.
• De Novo Classification Request: If no similar device exists, a new device may be classified through a De Novo request, which is a risk-based evaluation.

5. FDA Decision

• Clearance (510(k)): If the FDA determines that the device is substantially equivalent, it will issue a clearance letter.
• Approval (PMA): If the FDA determines that the device meets safety and efficacy standards, it will approve the device for marketing.
• De Novo Classification: If approved, the device is classified as a Class I or II device and can be marketed.

6. Post-Market Requirements

• Labeling Requirements: Devices must comply with FDA labeling requirements, including warnings, usage instructions, and adverse event reporting.
• Adverse Event Reporting: Manufacturers must report adverse events to the FDA through the MedWatch system.
• Device Tracking and Recalls: Manufacturers may need to track their devices and issue recalls if safety issues arise.

7. FDA Inspections and Compliance

• The FDA may inspect manufacturing facilities to ensure compliance with good manufacturing practices (GMP) and other regulatory requirements.
• Quality System Regulation (QSR): Manufacturers must establish and maintain a quality management system in compliance with FDA regulations.

Summary

In summary, the FDA certification process involves determining the device classification, preparing the necessary documentation, submitting the appropriate application (510(k), PMA, or De Novo), FDA review, and compliance with post-market regulations. Each step in the process varies depending on the risk classification of the device.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn